Looks like they are on track right now, but there is some devil in the details there, if some things don't go to plan i guess we will see them miss their target but by how much who knows?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025